Directed molecular evolution of antibodies;Évolution moléculaire dirigée d'anticorps

Journal de la Societe de Biologie

Volumn 200, Issue 4, 2006, Pages 355-363

  Dubreuil, Olivier ^a   Muller, Bruno ^a   Bossus, Marc ^a   Savatier, Alexandra ^a   Ducancel, Frédéric ^a  

^a DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CHIMERA; DIRECTED MOLECULAR EVOLUTION; GENETICS; HUMAN; METHODOLOGY; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CHIMERISM; DIRECTED MOLECULAR EVOLUTION; HUMANS; IMMUNOGLOBULIN G; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 34547627143     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2006039     Document Type: Review

References (21)

1. Arevalo J. H., Stura E. A., Taussig M. J. & Wilson I. A., Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J. Mol. Biol., 1993, 231, 103-118.
2. Boder E. T., Midelfort K. S. & Wittrup K. D., Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. P. N. A. S. USA, 2000, 97, 10701-10705.
3. Boulianne G. L., Hozumi N. & Shulman M. J., Production of functional chimaeric mouse/human antibody. Nature, 1984, 312, 643-646.
4. Brannigan J. A. & Wilkinson A. J., Protein engineering 20 years on. Nature Reviews, 2002, 3, 964-970.
5. Cadwell R. C. & Joyce G. F., Randomization of genes by PCR mutagenesis. Methods Appl., 1992, 2, 28-33.
6. Chowdhury P. S. & Pastan I., Improving antibody affinity by mimicking somatic hypermutaion in vitro. Nature Biotechnology, 1999, 17, 568-572.
7. Dall'Acqua W. F. & Carter P., Antibody engineering. Curent Opinion in Structural Biology, 1998, 8, 443-450.
8. Dall'Acqua W. F., Damschroder M. M., Zhang J., Woods R. M., Widjaja L., Yu J. & Wu H., Antibody humanization by framework shuffling. Methods, 2005, 36, 43-60.
9. Dubreuil O., Amélioration de la spécificité de reconnaissance d'un anticorps anti-progestérone par évolution moléculaire dirigée. Thèse de doctorat de l'Université Paris VI, 19 novembre 2004.
10. Dubreuil O., Bossus M., Graille M., Bilous M., Savatier A., Stura E., Jolivet M., Ménez A., & Ducancel F., Fine tuning of the specificity of an anti-progesterone antibody by first and second sphere residue engineering. J. Biol Chem., 2005, 280 (26), 24880-24887.
11. He M. & Taussig M. J., Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Research, 1997, 25, 5132-5134.
12. Hinfray J., Le phage display (Technoscope). 1998, 182, 1-11.
13. Holliger P. & Hudson P. J., Engineered antibody fragments and the rise of single domains. Nature Biotechnology, 2005, 23, 1126-1136.
14. Hoogenboom H. R., Selecting and screening recombinant antibody libraries. Nature Biotechnology, 2005, 23, 1105-1116.
15. Horton R. M., Hunt H. D., Ho S. N., Pullen J. K. & Pease L. R, Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, 1989, 77, 61-68.
16. Jonhson K. S. & Chiswell D. J., Human antibody engineering. Current Biology, 1993, 3, 564-571.
17. Kholer G. & Milstein C., Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975, 256, 495-497.
18. Nieba L., Krebber A. & Plückthun A., Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal. Biochem., 1996, 234, 155-165.
19. Owens R. J. & Young R. J., The genetic engineering of monoclonal antibodies. Journal of Immunological Methods, 1994, 168, 149-165.
20. Weiner L. M. & Carter P., Tunable antibodies. Nature Biotechnology, 2005, 23, 556-557.
21. Ying Khee Hwang W. & Foote J., Immunogenicity of engineered antibodies. Methods, 2005, 36, 3-10.